Literature DB >> 22038574

The impact of commercially available purinergic ligands on purinergic signalling research.

J R Flanaghan1, S J Roome.   

Abstract

Due to the extremely wide-spread expression of purinergic receptors, purinergic signalling has been implicated in numerous physiological and pathophysiological areas. To better understand the involvement of purinergic receptors in such areas, the researcher's requirement for diverse and varied purinergic receptor ligands has greatly increased. This has generated increased commercial opportunities for life science suppliers, and ultimately, has led to a rapid expansion in the number of commercially available purinergic receptor ligands. The wide-spread availability of ligands to researchers has greatly benefited the scientific community, nurturing the rapid and continued expansion of the purinergic signalling field.

Year:  2011        PMID: 22038574      PMCID: PMC3265706          DOI: 10.1007/s11302-011-9269-0

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  73 in total

1.  Dipyridamole suppresses high glucose-induced osteopontin secretion and mRNA expression in rat aortic smooth muscle cells.

Authors:  Ming-Song Hsieh; Wen-Bin Zhong; Shu-Chuan Yu; John Yi-Chung Lin; Wei-Ming Chi; Horng-Mo Lee
Journal:  Circ J       Date:  2010-04-20       Impact factor: 2.993

2.  On the role of P2X(7) receptors in dopamine nerve cell degeneration in a rat model of Parkinson's disease: studies with the P2X(7) receptor antagonist A-438079.

Authors:  Daniel Marcellino; Diana Suárez-Boomgaard; María Dolores Sánchez-Reina; José A Aguirre; Takashi Yoshitake; Shimako Yoshitake; Beth Hagman; Jan Kehr; Luigi F Agnati; Kjell Fuxe; Alicia Rivera
Journal:  J Neural Transm (Vienna)       Date:  2010-04-13       Impact factor: 3.575

3.  Effect of clopidogrel on nitric oxide levels in an ischemia reperfusion model.

Authors:  Muhip Kanko; Meltem Ozden; Hale Maral; Cigdem Acil
Journal:  J Cardiovasc Pharmacol       Date:  2006-07       Impact factor: 3.105

4.  Inhibition of platelet functions and thrombosis through selective or nonselective inhibition of the platelet P2 receptors with increasing doses of NF449 [4,4',4'',4'''-(carbonylbis(imino-5,1,3-benzenetriylbis-(carbonylimino)))tetrakis-benzene-1,3-disulfonic acid octasodium salt].

Authors:  Béatrice Hechler; Stéphanie Magnenat; Maddalena L Zighetti; Matthias U Kassack; Heiko Ullmann; Jean-Pierre Cazenave; Richard Evans; Marco Cattaneo; Christian Gachet
Journal:  J Pharmacol Exp Ther       Date:  2005-03-25       Impact factor: 4.030

5.  Evidence for involvement of Wnt signaling pathway in IB-MECA mediated suppression of melanoma cells.

Authors:  Pnina Fishman; Lea Madi; Sara Bar-Yehuda; Faina Barer; Luis Del Valle; Kamel Khalili
Journal:  Oncogene       Date:  2002-06-06       Impact factor: 9.867

Review 6.  Long-term (trophic) purinergic signalling: purinoceptors control cell proliferation, differentiation and death.

Authors:  G Burnstock; A Verkhratsky
Journal:  Cell Death Dis       Date:  2010       Impact factor: 8.469

7.  Recent improvements in the development of A(2B) adenosine receptor agonists.

Authors:  Pier Giovanni Baraldi; Mojgan Aghazadeh Tabrizi; Francesca Fruttarolo; Romeo Romagnoli; Delia Preti
Journal:  Purinergic Signal       Date:  2009-01-31       Impact factor: 3.765

8.  P2X7 regenerative-loop potentiation of glutamate synaptic transmission by microglia and astrocytes.

Authors:  Max R Bennett; Les Farnell; William G Gibson
Journal:  J Theor Biol       Date:  2009-07-28       Impact factor: 2.691

9.  Pharmacokinetic-haemodynamic relationships of 2-chloroadenosine at adenosine A1 and A2a receptors in vivo.

Authors:  R A Mathoôt; W Soudijn; D D Breimer; A P Ijzerman; M Danhof
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

10.  Caffeine and a selective adenosine A2A receptor antagonist induce sensitization and cross-sensitization behavior associated with increased striatal dopamine in mice.

Authors:  Chih W Hsu; Chin S Wang; Ted H Chiu
Journal:  J Biomed Sci       Date:  2010-01-15       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.